Macquarie Group’s Voyager Therapeutics VYGR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$18K	Hold	5,700	–	–	﹤0.01%	1618
2025 Q1	$19K	Hold	5,700	–	–	﹤0.01%	1592
2024 Q4	$32K	Hold	5,700	–	–	﹤0.01%	1568
2024 Q3	$33K	Hold	5,700	–	–	﹤0.01%	1604
2024 Q2	$45K	Hold	5,700	–	–	﹤0.01%	1614
2024 Q1	$53K	Hold	5,700	–	–	﹤0.01%	1560
2023 Q4	$48K	Hold	5,700	–	–	﹤0.01%	1588
2023 Q3	$44K	Hold	5,700	–	–	﹤0.01%	1587
2023 Q2	$65K	Hold	5,700	–	–	﹤0.01%	1600
2023 Q1	$44K	Hold	5,700	–	–	﹤0.01%	1635
2022 Q4	$35K	Hold	5,700	–	–	﹤0.01%	1678
2022 Q3	$34K	Hold	5,700	–	–	﹤0.01%	2047
2022 Q2	$34K	Hold	5,700	–	–	﹤0.01%	2153
2022 Q1	$43	Sell	5,700 -465	-8%	-$4	﹤0.01%	2187
2021 Q4	$16K	Hold	6,165	–	–	﹤0.01%	2453
2021 Q3	$16K	Hold	6,165	–	–	﹤0.01%	2488
2021 Q2	$26K	Hold	6,165	–	–	﹤0.01%	2312
2021 Q1	$29K	Sell	6,165 -220	-3%	-$1.04K	﹤0.01%	2198
2020 Q4	$46K	Hold	6,385	–	–	﹤0.01%	2057
2020 Q3	$68K	Hold	6,385	–	–	﹤0.01%	1879
2020 Q2	$81K	Buy	6,385 +685	+12%	+$8.69K	﹤0.01%	1814
2020 Q1	$52K	Hold	5,700	–	–	﹤0.01%	1801
2019 Q4	$80K	Hold	5,700	–	–	﹤0.01%	1810
2019 Q3	$98K	Hold	5,700	–	–	﹤0.01%	1741
2019 Q2	$155K	Hold	5,700	–	–	﹤0.01%	1628
2019 Q1	$109K	Buy	5,700 +5,400	+1,800%	+$103K	﹤0.01%	1522
2018 Q4	$3K	Hold	300	–	–	﹤0.01%	2164
2018 Q3	$6K	Sell	300 -1,700	-85%	-$34K	﹤0.01%	2054
2018 Q2	$39K	Buy	+2,000	New	+$39K	﹤0.01%	1980